Filter

Refine by collections

Refine by date

—

Refine by access

  • Print
  • Save

Search Results

You are looking at 1 - 10 of 989 items for :

  • Refine by access: All content x
Clear All
KeeMing Chia Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia
St Vincent’s Clinical School, Faculty of Medicine, UNSW Sydney, Darlinghurst, New South Wales, Australia

Search for other papers by KeeMing Chia in
Google Scholar
PubMed Close
,
Heloisa Milioli Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia
St Vincent’s Clinical School, Faculty of Medicine, UNSW Sydney, Darlinghurst, New South Wales, Australia

Search for other papers by Heloisa Milioli in
Google Scholar
PubMed Close
,
Neil Portman Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia
St Vincent’s Clinical School, Faculty of Medicine, UNSW Sydney, Darlinghurst, New South Wales, Australia

Search for other papers by Neil Portman in
Google Scholar
PubMed Close
,
Geraldine Laven-Law Dame Roma Mitchell Cancer Research Laboratories, Adelaide Medical School, University of Adelaide, Adelaide, South Australia, Australia

Search for other papers by Geraldine Laven-Law in
Google Scholar
PubMed Close
,
Rhiannon Coulson Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia
St Vincent’s Clinical School, Faculty of Medicine, UNSW Sydney, Darlinghurst, New South Wales, Australia

Search for other papers by Rhiannon Coulson in
Google Scholar
PubMed Close
,
Aliza Yong Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia
St Vincent’s Clinical School, Faculty of Medicine, UNSW Sydney, Darlinghurst, New South Wales, Australia

Search for other papers by Aliza Yong in
Google Scholar
PubMed Close
,
Davendra Segara St Vincent’s Clinical School, Faculty of Medicine, UNSW Sydney, Darlinghurst, New South Wales, Australia

Search for other papers by Davendra Segara in
Google Scholar
PubMed Close
,
Andrew Parker St Vincent’s Clinical School, Faculty of Medicine, UNSW Sydney, Darlinghurst, New South Wales, Australia

Search for other papers by Andrew Parker in
Google Scholar
PubMed Close
,
Catherine E Caldon Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia
St Vincent’s Clinical School, Faculty of Medicine, UNSW Sydney, Darlinghurst, New South Wales, Australia

Search for other papers by Catherine E Caldon in
Google Scholar
PubMed Close
,
Niantao Deng Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia
St Vincent’s Clinical School, Faculty of Medicine, UNSW Sydney, Darlinghurst, New South Wales, Australia

Search for other papers by Niantao Deng in
Google Scholar
PubMed Close
,
Alexander Swarbrick Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia
St Vincent’s Clinical School, Faculty of Medicine, UNSW Sydney, Darlinghurst, New South Wales, Australia

Search for other papers by Alexander Swarbrick in
Google Scholar
PubMed Close
,
Wayne D Tilley Dame Roma Mitchell Cancer Research Laboratories, Adelaide Medical School, University of Adelaide, Adelaide, South Australia, Australia

Search for other papers by Wayne D Tilley in
Google Scholar
PubMed Close
,
Theresa E Hickey Dame Roma Mitchell Cancer Research Laboratories, Adelaide Medical School, University of Adelaide, Adelaide, South Australia, Australia

Search for other papers by Theresa E Hickey in
Google Scholar
PubMed Close
, and
Elgene Lim Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia
St Vincent’s Clinical School, Faculty of Medicine, UNSW Sydney, Darlinghurst, New South Wales, Australia

Search for other papers by Elgene Lim in
Google Scholar
PubMed Close

Introduction The androgen receptor (AR) is a steroid hormone receptor that is important in the development of male-specific phenotype. AR has a well-established canonical function as a ligand-activated transcription factor involved in the

Article Type:
Research Article
DOI:
https://doi.org/10.1530/ERC-18-0333
Volume/Issue:
Volume 26: Issue 2
Free access
Raghavendra T K Poluri Département de médecine moléculaire, Faculté de médecine, Axe Endocrinologie – Néphrologie du Centre de recherche Centre Hospitalier Universitaire (CHU) de Québec – Université Laval, et Centre de recherche sur le cancer – Université Laval, Québec, Canada

Search for other papers by Raghavendra T K Poluri in
Google Scholar
PubMed Close
,
Virginie Paquette Département de médecine moléculaire, Faculté de médecine, Axe Endocrinologie – Néphrologie du Centre de recherche Centre Hospitalier Universitaire (CHU) de Québec – Université Laval, et Centre de recherche sur le cancer – Université Laval, Québec, Canada

Search for other papers by Virginie Paquette in
Google Scholar
PubMed Close
,
Éric P Allain Laboratoire de pharmacogénomique, Centre de recherche CHU de Québec – Université Laval et Faculté de Pharmacie, Université Laval, Centre de recherche sur le cancer – Université Laval, Québec, Canada

Search for other papers by Éric P Allain in
Google Scholar
PubMed Close
,
Camille Lafront Département de médecine moléculaire, Faculté de médecine, Axe Endocrinologie – Néphrologie du Centre de recherche Centre Hospitalier Universitaire (CHU) de Québec – Université Laval, et Centre de recherche sur le cancer – Université Laval, Québec, Canada

Search for other papers by Camille Lafront in
Google Scholar
PubMed Close
,
Charles Joly-Beauparlant Département de médecine moléculaire, Faculté de médecine, Axe Endocrinologie – Néphrologie du Centre de recherche Centre Hospitalier Universitaire (CHU) de Québec – Université Laval, et Centre de recherche sur le cancer – Université Laval, Québec, Canada

Search for other papers by Charles Joly-Beauparlant in
Google Scholar
PubMed Close
,
Cindy Weidmann Département de médecine moléculaire, Faculté de médecine, Axe Endocrinologie – Néphrologie du Centre de recherche Centre Hospitalier Universitaire (CHU) de Québec – Université Laval, et Centre de recherche sur le cancer – Université Laval, Québec, Canada

Search for other papers by Cindy Weidmann in
Google Scholar
PubMed Close
,
Arnaud Droit Département de médecine moléculaire, Faculté de médecine, Axe Endocrinologie – Néphrologie du Centre de recherche Centre Hospitalier Universitaire (CHU) de Québec – Université Laval, et Centre de recherche sur le cancer – Université Laval, Québec, Canada

Search for other papers by Arnaud Droit in
Google Scholar
PubMed Close
,
Chantal Guillemette Laboratoire de pharmacogénomique, Centre de recherche CHU de Québec – Université Laval et Faculté de Pharmacie, Université Laval, Centre de recherche sur le cancer – Université Laval, Québec, Canada

Search for other papers by Chantal Guillemette in
Google Scholar
PubMed Close
,
Martin Pelletier Département de microbiologie- infectiologie et d’immunologie, Faculté de médecine, Axe maladies infectieuses et immunitaires du Centre de Recherche du CHU de Québec – Université Laval et Centre de recherche ARThrite – Université Laval, Québec, Canada

Search for other papers by Martin Pelletier in
Google Scholar
PubMed Close
, and
Étienne Audet-Walsh Département de médecine moléculaire, Faculté de médecine, Axe Endocrinologie – Néphrologie du Centre de recherche Centre Hospitalier Universitaire (CHU) de Québec – Université Laval, et Centre de recherche sur le cancer – Université Laval, Québec, Canada

Search for other papers by Étienne Audet-Walsh in
Google Scholar
PubMed Close

radiotherapy, the standard of care for recurrent PCa is to block the androgen receptor (AR) ( Watson et al. 2015 , Wyatt et al. 2015 ). Despite the positive response of most PCa cases to inhibition of the androgen signaling pathway, cancer progression to

Article Type:
Research Article
DOI:
https://doi.org/10.1530/ERC-20-0504
Volume/Issue:
Volume 28: Issue 4
Restricted access
Varadha Balaji Venkadakrishnan Department of Cancer Biology, Cleveland Clinic, Cleveland, Ohio, USA
Department of Biological, Geological and Environmental Sciences, Cleveland State University, Cleveland, Ohio, USA

Search for other papers by Varadha Balaji Venkadakrishnan in
Google Scholar
PubMed Close
,
Salma Ben-Salem Department of Cancer Biology, Cleveland Clinic, Cleveland, Ohio, USA

Search for other papers by Salma Ben-Salem in
Google Scholar
PubMed Close
, and
Hannelore V Heemers Department of Cancer Biology, Cleveland Clinic, Cleveland, Ohio, USA

Search for other papers by Hannelore V Heemers in
Google Scholar
PubMed Close

receptor (AR), a ligand-activated transcription factor, drives CaP progression ( Huggins & Hodges 2002 , Dai et al. 2017 ). Therefore, blocking AR activation, known as androgen deprivation therapy (ADT), has been the default treatment for metastatic CaP

Article Type:
Review Article
DOI:
https://doi.org/10.1530/ERC-20-0048
Volume/Issue:
Volume 27: Issue 6
Free access
Garrett Daniels Department of Pathology, Department of Pathology, NYU Cancer Institute, Department of Urology, Department of Pharmacology, New York Harbor Healthcare System, New York University School of Medicine, New York, New York, USA

Search for other papers by Garrett Daniels in
Google Scholar
PubMed Close
,
Yirong Li Department of Pathology, Department of Pathology, NYU Cancer Institute, Department of Urology, Department of Pharmacology, New York Harbor Healthcare System, New York University School of Medicine, New York, New York, USA

Search for other papers by Yirong Li in
Google Scholar
PubMed Close
,
Lan Lin Gellert Department of Pathology, Department of Pathology, NYU Cancer Institute, Department of Urology, Department of Pharmacology, New York Harbor Healthcare System, New York University School of Medicine, New York, New York, USA

Search for other papers by Lan Lin Gellert in
Google Scholar
PubMed Close
,
Albert Zhou Department of Pathology, Department of Pathology, NYU Cancer Institute, Department of Urology, Department of Pharmacology, New York Harbor Healthcare System, New York University School of Medicine, New York, New York, USA

Search for other papers by Albert Zhou in
Google Scholar
PubMed Close
,
Jonathan Melamed Department of Pathology, Department of Pathology, NYU Cancer Institute, Department of Urology, Department of Pharmacology, New York Harbor Healthcare System, New York University School of Medicine, New York, New York, USA

Search for other papers by Jonathan Melamed in
Google Scholar
PubMed Close
,
Xinyu Wu Department of Pathology, Department of Pathology, NYU Cancer Institute, Department of Urology, Department of Pharmacology, New York Harbor Healthcare System, New York University School of Medicine, New York, New York, USA

Search for other papers by Xinyu Wu in
Google Scholar
PubMed Close
,
Xinming Zhang Department of Pathology, Department of Pathology, NYU Cancer Institute, Department of Urology, Department of Pharmacology, New York Harbor Healthcare System, New York University School of Medicine, New York, New York, USA

Search for other papers by Xinming Zhang in
Google Scholar
PubMed Close
,
David Zhang Department of Pathology, Department of Pathology, NYU Cancer Institute, Department of Urology, Department of Pharmacology, New York Harbor Healthcare System, New York University School of Medicine, New York, New York, USA

Search for other papers by David Zhang in
Google Scholar
PubMed Close
,
Daniel Meruelo Department of Pathology, Department of Pathology, NYU Cancer Institute, Department of Urology, Department of Pharmacology, New York Harbor Healthcare System, New York University School of Medicine, New York, New York, USA
Department of Pathology, Department of Pathology, NYU Cancer Institute, Department of Urology, Department of Pharmacology, New York Harbor Healthcare System, New York University School of Medicine, New York, New York, USA

Search for other papers by Daniel Meruelo in
Google Scholar
PubMed Close
,
Susan K Logan Department of Pathology, Department of Pathology, NYU Cancer Institute, Department of Urology, Department of Pharmacology, New York Harbor Healthcare System, New York University School of Medicine, New York, New York, USA
Department of Pathology, Department of Pathology, NYU Cancer Institute, Department of Urology, Department of Pharmacology, New York Harbor Healthcare System, New York University School of Medicine, New York, New York, USA
Department of Pathology, Department of Pathology, NYU Cancer Institute, Department of Urology, Department of Pharmacology, New York Harbor Healthcare System, New York University School of Medicine, New York, New York, USA

Search for other papers by Susan K Logan in
Google Scholar
PubMed Close
,
Ross Basch Department of Pathology, Department of Pathology, NYU Cancer Institute, Department of Urology, Department of Pharmacology, New York Harbor Healthcare System, New York University School of Medicine, New York, New York, USA

Search for other papers by Ross Basch in
Google Scholar
PubMed Close
, and
Peng Lee Department of Pathology, Department of Pathology, NYU Cancer Institute, Department of Urology, Department of Pharmacology, New York Harbor Healthcare System, New York University School of Medicine, New York, New York, USA
Department of Pathology, Department of Pathology, NYU Cancer Institute, Department of Urology, Department of Pharmacology, New York Harbor Healthcare System, New York University School of Medicine, New York, New York, USA
Department of Pathology, Department of Pathology, NYU Cancer Institute, Department of Urology, Department of Pharmacology, New York Harbor Healthcare System, New York University School of Medicine, New York, New York, USA
Department of Pathology, Department of Pathology, NYU Cancer Institute, Department of Urology, Department of Pharmacology, New York Harbor Healthcare System, New York University School of Medicine, New York, New York, USA

Search for other papers by Peng Lee in
Google Scholar
PubMed Close

Introduction It has long been known that androgens are critical in the growth and progression of prostate cancer ( Dehm & Tindall 2006 ). Androgens signal through the androgen receptor (AR), a member of the steroid receptor family of transcription

Article Type:
Research Article
DOI:
https://doi.org/10.1530/ERC-13-0293
Volume/Issue:
Volume 21: Issue 1
Free access
Jaesung (Peter) Choi ANZAC Research Institute, University of Sydney, Sydney, New South Wales, Australia

Search for other papers by Jaesung (Peter) Choi in
Google Scholar
PubMed Close
,
Yu Zheng ANZAC Research Institute, University of Sydney, Sydney, New South Wales, Australia

Search for other papers by Yu Zheng in
Google Scholar
PubMed Close
,
David J Handelsman ANZAC Research Institute, University of Sydney, Sydney, New South Wales, Australia

Search for other papers by David J Handelsman in
Google Scholar
PubMed Close
, and
Ulla Simanainen ANZAC Research Institute, University of Sydney, Sydney, New South Wales, Australia

Search for other papers by Ulla Simanainen in
Google Scholar
PubMed Close

steroidogenic conversion. Androgens mediate their specific effects via activation of the androgen receptor (AR) expressed in target tissues such as the uterus ( Somboonporn & Davis 2004 , Walters et al . 2010 ). AR is a member of the nuclear receptor

Article Type:
Research Article
DOI:
https://doi.org/10.1530/ERC-16-0039
Volume/Issue:
Volume 23: Issue 5
Free access
Mark Daniel Masonic Cancer Center, University of Minnesota
Graduate Program in Microbiology, Immunology, and Cancer Biology, University of Minnesota, Minneapolis, Minnesota, USA

Search for other papers by Mark Daniel in
Google Scholar
PubMed Close
,
Todd P Knutson University of Minnesota Supercomputing Institute, University of Minnesota, Minneapolis, Minnesota, USA

Search for other papers by Todd P Knutson in
Google Scholar
PubMed Close
,
Jamie M Sperger Department of Medicine, University of Wisconsin-Madison, Madison, Wisconsin, USA
Carbone Cancer Center, University of Wisconsin-Madison, Madison, Wisconsin, USA

Search for other papers by Jamie M Sperger in
Google Scholar
PubMed Close
,
Yingming Li Masonic Cancer Center, University of Minnesota

Search for other papers by Yingming Li in
Google Scholar
PubMed Close
,
Anupama Singh Carbone Cancer Center, University of Wisconsin-Madison, Madison, Wisconsin, USA

Search for other papers by Anupama Singh in
Google Scholar
PubMed Close
,
Charlotte N Stahlfeld Department of Medicine, University of Wisconsin-Madison, Madison, Wisconsin, USA
Carbone Cancer Center, University of Wisconsin-Madison, Madison, Wisconsin, USA

Search for other papers by Charlotte N Stahlfeld in
Google Scholar
PubMed Close
,
Courtney Passow University of Minnesota Genomics Center, University of Minnesota, Minneapolis, Minnesota, USA

Search for other papers by Courtney Passow in
Google Scholar
PubMed Close
,
Benjamin Auch University of Minnesota Genomics Center, University of Minnesota, Minneapolis, Minnesota, USA

Search for other papers by Benjamin Auch in
Google Scholar
PubMed Close
,
Joshua M Lang Department of Medicine, University of Wisconsin-Madison, Madison, Wisconsin, USA
Carbone Cancer Center, University of Wisconsin-Madison, Madison, Wisconsin, USA

Search for other papers by Joshua M Lang in
Google Scholar
PubMed Close
, and
Scott M Dehm Masonic Cancer Center, University of Minnesota
Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, Minnesota, USA
Department of Urology, University of Minnesota, Minneapolis, Minnesota, USA

Search for other papers by Scott M Dehm in
Google Scholar
PubMed Close

Introduction In the United States, prostate cancer (PC) is the second leading cause of male cancer deaths ( Siegel et al. 2020 ). Growth of PC cells is dependent on the androgen receptor (AR). Therefore, first- and second-generation hormonal

Article Type:
Research Article
DOI:
https://doi.org/10.1530/ERC-21-0157
Volume/Issue:
Volume 28: Issue 9
Restricted access
Mark P Labrecque Department of Urology, University of Washington School of Medicine, Seattle, Washington, USA

Search for other papers by Mark P Labrecque in
Google Scholar
PubMed Close
,
Joshi J Alumkal Department of Internal Medicine, Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan, USA

Search for other papers by Joshi J Alumkal in
Google Scholar
PubMed Close
,
Ilsa M Coleman Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA

Search for other papers by Ilsa M Coleman in
Google Scholar
PubMed Close
,
Peter S Nelson Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA
Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA
Department of Medicine, University of Washington School of Medicine, Seattle, Washington, USA

Search for other papers by Peter S Nelson in
Google Scholar
PubMed Close
, and
Colm Morrissey Department of Urology, University of Washington School of Medicine, Seattle, Washington, USA

Search for other papers by Colm Morrissey in
Google Scholar
PubMed Close

Castration-resistant prostate cancer Prostate cancer (PC) is notable for the dependence of tumor cells on the androgen receptor (AR) for activation of a luminal differentiation program, proliferation and survival. Because of this, androgen

Article Type:
Review Article
DOI:
https://doi.org/10.1530/ERC-21-0002
Volume/Issue:
Volume 28: Issue 8
Free access
Nelson Rangel Department of Medical Sciences, University of Turin, Turin, Italy
Natural and Mathematical Sciences Faculty, Universidad del Rosario, Bogotá, Colombia

Search for other papers by Nelson Rangel in
Google Scholar
PubMed Close
,
Milena Rondon-Lagos School of Biological Sciences, Universidad Pedagógica y Tecnológica de Colombia, Tunja, Colombia

Search for other papers by Milena Rondon-Lagos in
Google Scholar
PubMed Close
,
Laura Annaratone Department of Medical Sciences, University of Turin, Turin, Italy

Search for other papers by Laura Annaratone in
Google Scholar
PubMed Close
,
Simona Osella-Abate Department of Medical Sciences, University of Turin, Turin, Italy

Search for other papers by Simona Osella-Abate in
Google Scholar
PubMed Close
,
Jasna Metovic Department of Medical Sciences, University of Turin, Turin, Italy

Search for other papers by Jasna Metovic in
Google Scholar
PubMed Close
,
Maria Piera Mano Department of Surgical Sciences, University of Turin, Turin, Italy

Search for other papers by Maria Piera Mano in
Google Scholar
PubMed Close
,
Luca Bertero Department of Medical Sciences, University of Turin, Turin, Italy

Search for other papers by Luca Bertero in
Google Scholar
PubMed Close
,
Paola Cassoni Department of Medical Sciences, University of Turin, Turin, Italy

Search for other papers by Paola Cassoni in
Google Scholar
PubMed Close
,
Anna Sapino Department of Medical Sciences, University of Turin, Turin, Italy
Pathology Unit, Fondazione del Piemonte per l’Oncologia (FPO) Candiolo Cancer Institute (IRCCS), Candiolo, Italy

Search for other papers by Anna Sapino in
Google Scholar
PubMed Close
, and
Isabella Castellano Department of Medical Sciences, University of Turin, Turin, Italy

Search for other papers by Isabella Castellano in
Google Scholar
PubMed Close

contrast, the clinical and biological significance of androgen receptor (AR) expression in BC is not fully defined. AR positivity has been detected in up to 61% of primary and metastatic BC lesions ( Park et al. 2010 , Hu et al. 2011 , Yu et al

Article Type:
Research Article
DOI:
https://doi.org/10.1530/ERC-17-0417
Volume/Issue:
Volume 25: Issue 3
Free access
Francesco Caiazza School of Medicine, University College Dublin, Ireland
Centre for Colorectal Disease, St. Vincent’s University Hospital, Dublin, Ireland

Search for other papers by Francesco Caiazza in
Google Scholar
PubMed Close
,
Alyson Murray School of Medicine, University College Dublin, Ireland

Search for other papers by Alyson Murray in
Google Scholar
PubMed Close
,
Stephen F Madden Population Health Sciences, Department of Psychology, Royal College of Surgeons in Ireland, Dublin, Ireland

Search for other papers by Stephen F Madden in
Google Scholar
PubMed Close
,
Naoise C Synnott School of Medicine, University College Dublin, Ireland

Search for other papers by Naoise C Synnott in
Google Scholar
PubMed Close
,
Elizabeth J Ryan School of Medicine, University College Dublin, Ireland
Centre for Colorectal Disease, St. Vincent’s University Hospital, Dublin, Ireland

Search for other papers by Elizabeth J Ryan in
Google Scholar
PubMed Close
,
Norma O’Donovan National Institute for Cellular Biotechnology (NICB), Dublin City University, Dublin, Ireland

Search for other papers by Norma O’Donovan in
Google Scholar
PubMed Close
,
John Crown School of Medicine, University College Dublin, Ireland
Department of Medical Oncology, St. Vincent’s University Hospital, Dublin, Ireland

Search for other papers by John Crown in
Google Scholar
PubMed Close
, and
Michael J Duffy School of Medicine, University College Dublin, Ireland
UCD Clinical Research Centre, St. Vincent's University Hospital, Dublin, Ireland

Search for other papers by Michael J Duffy in
Google Scholar
PubMed Close

treat breast cancer and anti-androgens to treat prostate cancer ( Risbridger et al. 2010 ). However, a proportion of breast cancers contains androgen receptors (AR) ( Qu et al. 2013 , Vera-Badillo et al. 2014 ) and may thus be dependent on androgens

Article Type:
Research Article
DOI:
https://doi.org/10.1530/ERC-16-0068
Volume/Issue:
Volume 23: Issue 4
Free access
Xinyue Wang Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, People’s Republic of China

Search for other papers by Xinyue Wang in
Google Scholar
PubMed Close
,
Xiwen Bi Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, People’s Republic of China

Search for other papers by Xiwen Bi in
Google Scholar
PubMed Close
,
Zhangzan Huang Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, People’s Republic of China

Search for other papers by Zhangzan Huang in
Google Scholar
PubMed Close
,
Jiajia Huang Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, People’s Republic of China

Search for other papers by Jiajia Huang in
Google Scholar
PubMed Close
,
Wen Xia Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, People’s Republic of China

Search for other papers by Wen Xia in
Google Scholar
PubMed Close
,
Wei Shi Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, People’s Republic of China

Search for other papers by Wei Shi in
Google Scholar
PubMed Close
, and
Zhongyu Yuan Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, People’s Republic of China

Search for other papers by Zhongyu Yuan in
Google Scholar
PubMed Close

acquiring comprehensive information for metastatic tumors is needed to improve clinical outcomes. Similar to ER and PR, androgen receptor (AR) is a member of the steroid nuclear receptor family ( Basile et al . 2017 ), playing an important role in the

Article Type:
Research Article
DOI:
https://doi.org/10.1530/ERC-19-0315
Volume/Issue:
Volume 27: Issue 4
Free access